Home  »  Finance   »  Olink Holding AB (publ) ADR (OLK) Sits On Its Hand...

Olink Holding AB (publ) ADR (OLK) Sits On Its Hands At $24.22

Olink Holding AB (publ) ADR (NASDAQ:OLK) concluded the trading at $24.22 Friday, February 09 with a fall of -0.62% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $24.37 and 5Y monthly beta was reading 0.55 . Considering stock’s 52-week price range provides that OLK hit a high price of $26.01 and saw its price falling to a low level of $14.10 during that period. Over a period of past 1-month, stock came subtracting -2.81% in its value.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

With its current market valuation of $2.99 billion, Olink Holding AB (publ) ADR is set to declare its quarterly results on Feb 19, 2024 – Feb 23, 2024. Analysts are in estimates of $0.15 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.04 for 2023 with estimates of that growing to $0.02 in next year. These estimates are suggesting current year growth of 63.60% for EPS and 150.00% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $89.86 million. They suggested that in the process company could generate revenue of as low as $82.8 million which could climb up to $94.95 million to hit a high. The average estimate is representing an increase of 55.20% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $190.89 million in 2023, which will be 36.50% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review OLK stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 100% Buy for it.

Digging deeper we become aware of the PEG ratio of the OLK stock which is currently positioned at 0. It further provides that stock’s current price level is -2.48% away from its 20-day simple moving average and is -4.15% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 23.08 while volatility remained at 0.95% over the past week which changes to 0.88% when measuring it over the past month. Beta is valued at 0.54, while measure of average true range or ATR is currently at 0.23.

In comparing Olink Holding AB (publ) ADR (OLK)’s stock with other industry players reveals that stock’s current price change of -0.62% and that of 7.12% over the past 12 months is in competing position with that of 10x Genomics Inc. (TXG) which saw its stock price raised by 2.21%% in the last trading and went through an increase of 14.11% in past 12-month trading. Industry’s another major player Pacific Biosciences of California Inc. (PACB) has rise 1.37%% up in previous session, but over the past year has faced a fall of -34.00%. Olink Holding AB ADR (OLK) was also down -0.62%% however its price remained floating in the green at 12.81% over the same period. Olink Holding AB (publ) ADR has a P/E ratio of 0.

Having a second look at Olink Holding AB (publ) ADR (NASDAQ:OLK) provides that stock’s average daily trading volume for 3 months was 1.09 million, while it jumped to 0.97 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 123.35 million.

The percentage of outstanding shares held by the insiders is 0.65% while it is 32.79% for the institutional holders. The figures also indicate that as of Jan 12, 2024, number of stock’s short shares was 2.15 million which implies a short ratio of 2.06. This shows down a 1.73% of Short Interest in company’s outstanding shares on the day. In January the standing of shares short improved as it was 2.34 million in the previous month. Subtraction of -3.70% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.